SPX3,911.74+116.01 3.06%
DIA315.02+8.28 2.70%
IXIC11,607.62+375.43 3.34%

BRIEF-Immunome Announces Initiation Of Phase 1B Study Of Imm-Bcp-01 For The Treatment Of Covid-19

reuters.com · 06/09/2022 08:04
BRIEF-Immunome Announces Initiation Of Phase 1B Study Of Imm-Bcp-01 For The Treatment Of Covid-19

- Immunome Inc IMNM:

  • IMMUNOME ANNOUNCES INITIATION OF PHASE 1B STUDY OF IMM-BCP-01 FOR THE TREATMENT OF COVID-19

  • IMMUNOME INC - TOPLINE DATA IS EXPECTED IN SECOND HALF OF THIS YEAR, WHICH IS AN UPDATE FROM OUR PRIOR GUIDANCE

Source text for Eikon: ID:nBwbzTfjWa

Further company coverage: IMNM


((reuters.briefs@thomsonreuters.com;))